V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330003856 | 330001929 | 1.7 | null | Curative (C) | 2014-04-26 | 2014-05-01 | EW EuroEwing 2012 Arm A VIDE | N | N | 330014583 | EURO-EWING |
| 330003857 | 330001930 | 1.58 | 47.9 | Curative (C) | 2014-03-18 | 2014-03-18 | CETUXIMAB + RT | 2 | N | 330014596 | CETUXIMAB + RT |
| 330003858 | 330001930 | 1.56 | null | Curative (C) | 2014-07-27 | 2014-07-30 | Cetuximab 7 day (Cycle 1) | 02 | Y | 330014596 | CETUXIMAB |
| 330003859 | 330001931 | 1.65 | 60 | null | 2013-09-11 | 2013-09-11 | CAP | null | null | 330014618 | CAP |
| 330003860 | 330001931 | 1.68 | 70 | Curative (C) | 2017-08-02 | 2017-08-10 | Cetuximab + Radiotherapy Maint | null | null | 330014618 | CETUXIMAB + RT |
| 330003861 | 330009815 | 1.55 | 64.6 | Curative (C) | 2015-03-08 | 2015-03-18 | Cisplatin + Etoposide po&iv 3 day | N | N | 330014639 | CISPLATIN + ETOPOSIDE |
| 330003862 | 330009815 | 1.58 | 55 | Curative (C) | 2017-08-08 | 2017-08-15 | OST Euramos 1 Closed Trial - AP | N | N | 330014639 | MAP |
| 330003863 | 330001932 | 1.77 | 64.5 | Neo-adjuvant (N) | 2013-08-02 | 2013-08-07 | Dox + HD Mtx (post PAM) | N | N | 330014643 | DOXORUBICIN + HD MTX |
| 330003864 | 330001933 | 1.63 | 56 | Curative (C) | 2014-04-18 | 2014-04-29 | Cisplatin + Etoposide (3 day) | 02 | N | 330014645 | CISPLATIN + ETOPOSIDE |
| 330003865 | 330001933 | 1.68 | null | Curative (C) | 2017-03-03 | 2017-03-13 | Cetuximab + Radiotherapy Load | N | null | 330014645 | CETUXIMAB + RT |
| 330003866 | 330001933 | 1.72 | 101.1 | Palliative (P) | 2014-10-14 | 2014-10-14 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330014645 | CISPLATIN + GEMCITABINE |
| 330003867 | 330001934 | 1.69 | null | Palliative (P) | 2013-08-02 | 2013-08-16 | Dox + HD Mtx (post PAM) | N | null | 330014652 | DOXORUBICIN + HD MTX |
| 330003868 | 330001935 | 1.69 | 78 | Palliative (P) | 2014-11-07 | 2014-11-18 | Cisplatin + Etoposide po&iv 3 day | N | N | 330014668 | CISPLATIN + ETOPOSIDE |
| 330003870 | 330007052 | 0 | 81.8 | null | 2017-05-12 | 2017-05-12 | CVP R | N | N | 330014687 | CVP R |
| 330003873 | 330001938 | 1.77 | 82 | Palliative (P) | 2013-03-28 | 2013-03-28 | GemCarbo Days 1+8 | 2 | N | 330014695 | GEMCARBO |
| 330003874 | 330001939 | 1.62 | 97 | Neo-adjuvant (N) | 2013-01-14 | 2013-01-14 | EURO-EWING | N | null | 330014699 | EURO-EWING |
| 330003875 | 330001939 | 1.72 | 69.5 | Neo-adjuvant (N) | 2015-11-29 | 2015-12-02 | EURAMOS TRIAL | 2 | N | 330014699 | EURAMOS TRIAL |
| 330003878 | 330009817 | 1.88 | 84.3 | Curative (C) | 2016-06-18 | 2016-06-18 | CETUXIMAB + RT | 2 | Y | 330014727 | CETUXIMAB + RT |
| 330003879 | 330009817 | 1.58 | 79.3 | Curative (C) | 2015-05-18 | 2015-06-06 | CETUXIMAB + RT | N | Y | 330014727 | CETUXIMAB + RT |
| 330003880 | 330001941 | 1.91 | 53.85 | null | 2013-03-06 | 2013-03-07 | Carbo F | N | null | 330014736 | CARBO + FLUOROURACIL |
| 330003881 | 330007056 | null | 54.9 | Disease modification (D) | 2016-07-16 | 2016-07-22 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 330014737 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003882 | 330007056 | 1.52 | 40.8 | Neo-adjuvant (N) | null | 2013-08-28 | Dox + HD Mtx (post PAM) | null | null | 330014737 | DOXORUBICIN + HD MTX |
| 330003883 | 330007056 | 1.68 | 63.5 | Palliative (P) | 2013-08-03 | 2013-08-03 | CISPLATIN + ETOPOSIDE | Y | N | 330014737 | CISPLATIN + ETOPOSIDE |
| 330003884 | 330007056 | 1.84 | 29.2 | Neo-adjuvant (N) | 2013-09-06 | 2013-09-20 | EURAMOS TRIAL | N | N | 330014737 | EURAMOS TRIAL |
| 330003885 | 330012668 | null | 70.2 | Curative (C) | 2014-07-11 | 2014-08-02 | CVP R | N | null | 330014753 | CVP R |
| 330003886 | 330012668 | 1.59 | 85.7 | Palliative (P) | 2014-01-06 | 2014-01-11 | Dox + HD Mtx (post PAM) | N | N | 330014753 | DOXORUBICIN + HD MTX |
| 330003887 | 330001942 | 1.66 | 80.8 | Palliative (P) | 2017-05-08 | 2017-05-10 | Cyclophosphamide + Dex + Rituximab | 02 | N | 330014760 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003888 | 330001942 | 0 | 64.1 | Curative (C) | 2014-08-09 | 2014-08-09 | EURAMOS TRIAL | N | N | 330014760 | EURAMOS TRIAL |
| 330003889 | 330001943 | null | 41.4 | Curative (C) | 2013-07-13 | 2013-07-15 | OST Euramos 1 Closed Trial - AP | N | N | 330014770 | MAP |
| 330003890 | 330001944 | 1.62 | 71.8 | Palliative (P) | 2016-01-01 | 2016-01-21 | Cyclophosphamide + Dex + Rituximab | N | N | 330014775 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330003891 | 330001945 | 1.66 | 57 | Neo-adjuvant (N) | 2013-05-23 | 2013-06-18 | EURAMOS TRIAL | 2 | N | 330014776 | EURAMOS TRIAL |
| 330003892 | 330001946 | 1.6 | 61 | Neo-adjuvant (N) | 2016-08-03 | 2016-08-08 | Dox + HD Mtx (post PAM) | 02 | N | 330014777 | DOXORUBICIN + HD MTX |
| 330003893 | 330001947 | 1.84 | 62 | Curative (C) | 2014-12-23 | 2014-12-25 | MAP | 02 | N | 330014785 | MAP |
| 330003894 | 330001947 | 1.85 | 72.9 | Palliative (P) | 2015-03-10 | 2015-03-15 | Carbo F | N | N | 330014785 | CARBO + FLUOROURACIL |
| 330003895 | 330001948 | 1.7 | 81.8 | Palliative (P) | 2013-10-11 | 2013-12-06 | GemCarbo Days 1+8 | N | N | 330014791 | GEMCARBO |
| 330003896 | 330001949 | 1.57 | 79 | Palliative (P) | 2013-09-20 | 2013-09-23 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 330014797 | CISPLATIN + GEMCITABINE |
| 330003898 | 330001950 | 1.62 | 56 | Palliative (P) | 2013-05-15 | 2013-06-05 | Cisplatin + Etoposide po&iv 3 day | N | N | 330014800 | CISPLATIN + ETOPOSIDE |
| 330003899 | 330007060 | null | 81 | null | 2017-04-16 | 2017-04-28 | DA 3 + 10 | N | N | 330014817 | DA |
| 330003900 | 330007060 | 1.68 | 65.9 | Palliative (P) | 2014-03-12 | 2014-03-30 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 330014817 | CISPLATIN + GEMCITABINE |
| 330003901 | 330001951 | 1.6 | 70 | Neo-adjuvant (N) | 2014-04-21 | 2014-04-26 | Dox + HD Mtx (post PAM) | 02 | N | 330014822 | DOXORUBICIN + HD MTX |
| 330003902 | 330001951 | 1.87 | 71 | Neo-adjuvant (N) | 2017-02-27 | 2017-03-11 | EW EuroEwing 99 : VIDE | N | N | 330014822 | EURO-EWING |
| 330003903 | 330001951 | 1.8 | 23 | null | 2016-08-17 | 2016-08-20 | Carbo F | N | N | 330014822 | CARBO + FLUOROURACIL |
| 330003904 | 330001951 | null | null | Neo-adjuvant (N) | 2015-07-20 | 2015-07-20 | Carbo F | N | N | 330014822 | CARBO + FLUOROURACIL |
| 330003905 | 330001952 | 1.7 | 102 | Palliative (P) | 2017-02-19 | 2017-02-20 | CARBOPLATIN + FLUOROURACIL | 02 | null | 330014844 | CARBO + FLUOROURACIL |
| 330003906 | 330001952 | 1.72 | 81.6 | Curative (C) | 2017-04-03 | 2017-04-03 | EW EuroEwing 2012 Arm A VIDE | 02 | N | 330014844 | EURO-EWING |
| 330003907 | 330001952 | 1.77 | 63.5 | null | 2017-09-19 | 2017-09-21 | CVP R | Y | N | 330014844 | CVP R |
| 330003908 | 330001953 | null | 36.2 | Curative (C) | 2015-12-15 | 2015-12-23 | OST Euramos 1 Closed Trial - AP | N | N | 330014852 | MAP |
| 330003909 | 330007063 | 1.86 | 52 | Curative (C) | 2013-09-14 | 2013-09-27 | Cetuximab + Radiotherapy Load | Y | N | 330014854 | CETUXIMAB + RT |
| 330003910 | 330007063 | null | 78.9 | Curative (C) | null | 2015-12-01 | DA | null | null | 330014854 | DA |
| 330003911 | 330007063 | 1.64 | 58 | Not known (9) | 2015-04-25 | 2015-04-26 | CVP R | 02 | null | 330014854 | CVP R |